Document Detail


Women and peripheral arterial disease.
MedLine Citation:
PMID:  19863470     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Peripheral arterial disease is a major cause of morbidity and mortality in Americans. Without aggressive management of the disease as well as comorbidities and risk factors, peripheral arterial disease may progress and place patients at risk for amputation of the affected limb. In addition, patients affected by peripheral arterial disease are at increased risk for death from both cardiovascular and noncardiovascular causes. Although traditionally felt to be a disease of Caucasian men, women compose a significant portion of patients with peripheral arterial disease, especially among the elderly. Increased prevalence of asymptomatic disease in women can lead to delayed diagnosis and treatment. Without the appropriate medical and or surgical intervention, women are at risk of poor procedural outcomes and increased mortality. This review will focus on the differences in peripheral arterial disease based on gender and how these differences can affect the presentation, diagnosis and treatment of peripheral arterial disease in women.
Authors:
Ashley K Vavra; Melina R Kibbe
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Women's health (London, England)     Volume:  5     ISSN:  1745-5065     ISO Abbreviation:  -     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-29     Completed Date:  2010-01-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101271249     Medline TA:  Womens Health (Lond Engl)     Country:  England    
Other Details:
Languages:  eng     Pagination:  669-83     Citation Subset:  IM    
Affiliation:
Division of Vascular Surgery, Northwestern Feinberg School of Medicine, Chicago, IL, USA. ashleyvavra@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age Factors
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Aspirin / therapeutic use
Biological Markers / analysis
C-Reactive Protein / biosynthesis
Cardiovascular Agents / therapeutic use
Comorbidity
Estrogen Replacement Therapy
Exercise
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Male
Peripheral Vascular Diseases / diagnosis,  epidemiology*,  therapy*
Postmenopause
Prevalence
Risk Factors
Sex Factors
Smoking
Women's Health*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Biological Markers; 0/Cardiovascular Agents; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 50-78-2/Aspirin; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Embryonic development and pregnancy test sensitivity: the importance of earlier pregnancy detection.
Next Document:  Lung cancer: a biologically different disease in women?